May 13 (Reuters) - Indian generic drugmaker Ranbaxy Laboratories Ltd pleaded guilty on Monday to felony charges related to drug safety and will pay $500 million in civil and criminal fines under the settlement agreement with the U.S. Department of Justice.
May 13 (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd pleaded guilty on Monday to felony charges related to drug safety and will pay $500 million in civil and criminal fines under the settlement agreement with the U.S. Department of Justice.
May 13 (Reuters) - Ranbaxy Laboratories Ltd : * U.S. Justice Department says Ranbaxy Laboratories Ltd unit pleads
MUMBAI, May 8 (Reuters) - Ranbaxy Laboratories , India's largest drugmaker by sales, reported a 90 percent drop in first quarter net profit compared to the same year-ago …
… Absorica (CIP-Isotretinoin) at Ranbaxy ( RBXLY.OB ), and continued growth ..... transfer pricing on U.S. sales at Ranbaxy . We note that Cipher receives a ..... royalty on U.S. sales of Absorica at Ranbaxy , meaning that sales in the first …
… Astellas Pharma registered a quarterly gain of 30.58%, while Daiichi Sankyo Co. Ltd is up 36.91%. India's Lupin Ltd. is up a modest 2.4% but Ranbaxy Laboratories RBXD slumped 13.11%. Among exporters, Tokyo-listed car manufacturer …
… its crown jewel, sales of Lipitor fell by 50% the first week it went off patent in late December 2011. But for Ranbaxy Laboratories , it was a watershed moment, reaping $500 million in sales for its generic version of Lipitor in just the first …
MUMBAI, Feb 26 (Reuters) - Ranbaxy Laboratories Ltd , India's top drugmaker by sales, said its base business would grow a modest 10 percent in 2013 after reporting a surprise quarterly loss on product recall charges, sending its shares down more than 4 percent.
MUMBAI, Feb 26 (Reuters) - Ranbaxy Laboratories Ltd , India's top drugmaker by sales, reported a quarterly net loss of 4.92 billion rupees ($91.30 million) after setting …
Feb 22 (Reuters) - Indian generic drugmaker Ranbaxy Laboratories Ltd said on Friday it will resume production of its version ..... resolving the issues that led to a November recall. Ranbaxy in November recalled its atorvastatin from the U …